Related Articles
Bufalin attenuates triple‑negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
MELK as a potential target to control cell proliferation in triple‑negative breast cancer MDA‑MB‑231 cells
Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways